Chi Luo
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Cell Adhesion Molecules Research 3
- Co-authors
- Pere PuigserverHans R. WidlundAllen B. ReitzFrancisca VázquezAlfonzo D. JordanJinghao ShengAhmed GehadJames G. Krueger
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)Cancer Research (3 papers)Nature Communications (2 papers)Nature (2 papers)Cancers (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Chi Luo
40 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 378
- Immunology 524
- Molecular Biology 897
- Oncology 261
- Physiology 195
Countries citing papers authored by Chi Luo
This map shows the geographic impact of Chi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Luo more than expected).
Fields of papers citing papers by Chi Luo
This network shows the impact of papers produced by Chi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Luo. The network helps show where Chi Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 5 | |
| 7 | Prothrombin complex concentrates and andexanet for management of direct factor Xa inhibitor related bleeding: a meta-analysis | 2021 | 5 |
| 8 | 2021 | 6 | |
| 9 | 2021 | 32 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 38 | |
| 13 | 2020 | 142 | |
| 14 | 2017 | 42 | |
| 15 | 2016 | 162 | |
| 16 | 2014 | 73 | |
| 17 | 2013 | 25 | |
| 18 | 2006 | 11 | |
| 19 | 2001 | 17 | |
| 20 | 1996 | 85 |
About Chi Luo
Chi Luo is a scholar working on Immunology and Allergy, Biochemistry, Molecular Biology, Cancer Research and Hematology, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Melanoma and MAPK Pathways (5 papers), Protein Degradation and Inhibitors (3 papers), Cell Adhesion Molecules Research (3 papers), Heavy Metal Exposure and Toxicity (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Mitochondrial Function and Pathology (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Cancer Research (378 citations), Immunology (524 citations), Molecular Biology (897 citations), Oncology (261 citations) and Physiology (195 citations). Chi Luo has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Pere Puigserver, Hans R. Widlund, Allen B. Reitz, Francisca Vázquez, Alfonzo D. Jordan, Jinghao Sheng, Ahmed Gehad, James G. Krueger, Rachael A. Clark and Xing Liu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Nature Communications, Nature and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.